© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Latest Conference Articles
Flexible Dosing in in Atopic Dermatitis Treatment: Notes on Real-World Use with Raj Chovatiya, MD, PhD, MSCI
June 11th 2025
Revolutionizing Atopic Dermatitis (RAD)
RAD 2025: Chovatiya spoke at RAD about the need to better understand how treatments for AD are being used in the real world, after symptoms subside and skin signs clear.
Understanding Chronic Hand Eczema: More Than Just Atopic Dermatitis
June 10th 2025
Revolutionizing Atopic Dermatitis (RAD)
RAD 2025: Jiade Yu, MD, discussed chronic hand eczema as a distinct condition from AD, highlighting its clinical burden and emerging treatments, such as delgocitinib.
2025 ACOG Annual Clinical & Scientific Meeting: What You May Have Missed
June 10th 2025
From primary care management of heavy menstrual bleeding to postpartum depression screening, find out what you may have missed at ACOG 2025.
Q&A: Cumulative Life Course Impairment of Atopic Dermatitis with Mona Shahriari, MD
June 10th 2025
Revolutionizing Atopic Dermatitis (RAD)
RAD 2025: As expert dermatologist Shahriari explains it, eczema may be just another rash on your schedule but for a patient, it could be the reason they don't leave the house.
Chronic Hand Eczema: Clinical Insights and Future Directions from RAD 2025
June 10th 2025
Revolutionizing Atopic Dermatitis (RAD)
RAD 2025: Explore expert insights on chronic hand eczema, its differences from atopic dermatitis, and emerging treatments in this informative video series.
Upadacitinib Shows Real-World Efficacy in Bio-Naïve, Bio-Experienced Adults with Atopic Dermatitis in New Study
June 9th 2025
Revolutionizing Atopic Dermatitis (RAD)
RAD 2025: Many adults achieved optimal treatment targets with upadacitinib after 6 months, regardless of prior biologic therapy, according to new late-breaking data.
Q&A: Managing Chronic Itch With Renowned Investigator Gil Yosipovitch, MD
June 9th 2025
Revolutionizing Atopic Dermatitis (RAD)
RAD 2025: World expert on the pathophysiology of itch Gil Yosipovitch, MD, answers questions on the disease of chronic itch and on the expanding options for targeted treatment.
Beyond the Rash: Collaborative Insights on Pediatric Atopic Dermatitis
June 9th 2025
Revolutionizing Atopic Dermatitis (RAD)
RAD 2025: Lisa Swanson, MD, shares insights on pediatric atopic dermatitis, addressing questions from both a dermatologist's and an allergist's perspective.
Persistent Underutilization of Systemic Therapy for Atopic Dermatitis Highlights Gap Between Need and Care
June 9th 2025
Revolutionizing Atopic Dermatitis (RAD)
RAD 2025: Mobile health data reveal a troubling decline in systemic treatment for moderate-to-severe atopic dermatitis, underscoring issues in access and clinical inertia.
Dupilumab Monotherapy Improves AD Severity and Pigmentation in People With Skin of Color
June 9th 2025
Revolutionizing Atopic Dermatitis (RAD)
Dupilumab monotherapy showed significant improvements in atopic dermatitis symptoms in patients with skin of color, according to late-breaking data presented at RAD 2025.